Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

10/08/2026 07:33

    Aug 10 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             16.05               15.50            63.20    
                 (+3.5 pct)          (+6.0 pct)       (+1.4 pct)  
  Operating        972 mln             596 mln            2.00    
                 (+63.0 pct)         (-48.1 pct)      (-24.2 pct) 
  Recurring        911 mln             647 mln            1.40    
                 (+40.9 pct)         (-28.8 pct)      (-40.4 pct) 
  Net              642 mln             462 mln            1.30    
                 (+39.0 pct)         (-26.9 pct)      (-35.4 pct) 
  EPS             75.30 yen           54.14 yen       152.25 yen  
  Ann Div                             90.00 yen        90.00 yen  
  -Q2 div                             45.00 yen        45.00 yen  
  -Q4 div                             45.00 yen        45.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T